The FDA on Tuesday issued a warning that the antipsychotic olanzapine may cause a rare but serious s...

APA this week released the Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psy...

The Food and Drug Administration (FDA) on Friday approved Nuplazid (pimavanserin) tablets, the first...

Patients with schizophrenia who take antipsychotics commonly experience serious adverse metabolic ef...

Following an acute manic episode, many patients with bipolar disorder are treated with a combination...

An eight-week, randomized, controlled study published today in AJP in Advance has found that a 1.5 m...

APA has endorsed new Senate legislation requiring Medicare Part D plans to provide robust coverage f...

An analysis of 212 clinical trials of 15 antipsychotic medications found that all were significantly...